Source: Virtual Congress 2021 – New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes



Rating:

Share or cite this content

Citations should be made in the following way:
M. Freitas Ferreira Araújo (Braga, Portugal), A. Carvalho (Porto, Portugal), E. Padrão (Braga, Portugal), H. Novais Bastos (Porto, Portugal), N. Melo (Porto, Portugal), P. Mota (Porto, Portugal), A. Morais (Porto, Portugal). Disease behaviour and prognostic factors in Hypersensitivity Pneumonitis with UIP-like pattern. 2970

Member's Comments

No comment yet.

Related content which might interest you: Annual changes in pulmonary function are independent prognostic factors for the patients with chronic hypersensitivity pneumonia Source: International Congress 2014 – ILDs 3 Year: 2014 Cryptogenic organising pneumonia focusing on its prognostic determinants Source: International Congress 2014 – ILDs 4 Year: 2014 Prognostic factors in chronic hypersensitivity pneumonitis Source: Eur Respir Rev, 29 (156) 190167; 10.1183/16000617.0167-2019 Year: 2020 Impact Prognostic impact of comorbidities in patients with chronic Hypersensitivity Pneumonitis Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018 Anti-synthetase syndrome associated Interstitial Lung Disease (ASS-ILD): clinical heterogeneity and outcome Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Chronic Hypersensitivity Pneumonitis and mortality: impact of comorbidities Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases Year: 2020 Chronic hypersensitivity pneumonitis: Is the interstitial pneumonias disease behavior classification suitable for outcome stratification? Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Prognostic factors in Korean patients with chronic hypersensitivity pneumonitis Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018 Occupational and environmental risk factors for Idiopathic Pulmonary Fibrosis in Australia Source: International Congress 2018 – Occupational and environmental lung diseases: air quality and lung damage Year: 2018 Anti-synthetase syndrome associated Interstitial Lung Disease (ASS-ILD): Clinical, serological and radiological heterogeneity Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Angiopoietin-2 gene polymorphism as prognostic factor in caucasians with idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 1 Year: 2014 Clinical features and prognosis of 108 patients with lymphangioleiomyomatosis Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations Year: 2014 Prognostic influence of comorbidities in idiopathic pulmonary fibrosis (IPF) Source: International Congress 2014 – ILDs 2 Year: 2014 Prognostic characteristics in chronic hypersensitivity pneumonitis. Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Assessment of Treatment Response in Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019 Morality predictors in acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 6 Year: 2014 Recurrence predictive factors of cryptogenic organizing pneumonia Source: International Congress 2015 – Connective tissue disorders Year: 2015 Mortality and survival predictor in chronic hypersensitivity pneumonitis Source: International Congress 2016 – Sarcoidosis Year: 2016 Verification of genetic associations with Scleroderma associated Interstitial Lung Disease Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 Desquamative interstitial pneumonia in a Danish cohort, treatment response and outcome Source: International Congress 2014 – ILDs 2 Year: 2014